Inventor
XIE YONGPING
US24 patents
⚠️ This page may combine multiple inventors who share the name “XIE YONGPING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
8 patentsUS9850230B2Dec 26, 2017
Compounds and compositions as protein kinase inhibitors
ARRAY BIOPHARMA INC7 citations92
US9593099B2Mar 14, 2017
Compounds and compositions as protein kinase inhibitors
ARRAY BIOPHARMA INC7 citations92
US10005761B2Jun 26, 2018
Compounds and compositions as protein kinase inhibitors
ARRAY BIOPHARMA INC3 citations84
US9850229B2Dec 26, 2017
Compounds and compositions as protein kinase inhibitors
ARRAY BIOPHARMA INC5 citations84
US9593100B2Mar 14, 2017
Compounds and compositions as protein kinase inhibitors
ARRAY BIOPHARMA INC7 citations84
US10576080B2Mar 3, 2020
Compounds and compositions as protein kinase inhibitors
ARRAY BIOPHARMA INC1 citations73
US10568884B2Feb 25, 2020
Compounds and compositions as protein kinase inhibitors
ARRAY BIOPHARMA INC1 citations73
USRE49556EJun 20, 2023
Compounds and compositions as protein kinase inhibitors
ARRAY BIOPHARMA INC0 citations62
IRM LLC
6 patentsUS7868018B2Jan 11, 2011
Compounds and compositions as protein kinase inhibitors
IRM LLC11 citations84
US7449582B2Nov 11, 2008
Compounds and compositions as protein kinase inhibitors
IRM LLC15 citations83
US7572811B2Aug 11, 2009
Immunosuppressant compounds and compositions
IRM LLC11 citations82
US7846923B2Dec 7, 2010
Compounds and compositions as protein kinase inhbitors
IRM LLC5 citations62
US7750032B2Jul 6, 2010
Compounds and compositions as PPAR modulators
IRM LLC0 citations50
US7820705B2Oct 26, 2010
Compounds and compositions as PPAR modulators
IRM LLC0 citations36
NOVARTIS AG
3 patentsUS9314464B2Apr 19, 2016
Compounds and compositions as protein kinase inhibitors
NOVARTIS AG7 citations84
US8026243B2Sep 27, 2011
[4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors
NOVARTIS AG2 citations63
US11384078B2Jul 12, 2022
5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
NOVARTIS AG1 citations55